Education
About Us
Working with TipRanks
Follow Us
LakeShore Biopharma (LSB)
NASDAQ:LSB
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 614.96M | ¥ 573.42M | ¥ 687.20M | ¥ 502.95M | ¥ 257.02M |
| Gross Profit | ¥ 507.19M | ¥ 455.73M | ¥ 533.84M | ¥ 385.88M | ¥ 197.36M |
| Operating Income | ¥ -86.29M | ¥ -445.83M | ¥ -139.38M | ¥ -549.18K | ¥ -125.85M |
| EBITDA | ¥ -48.54M | ¥ -368.66M | ¥ -76.80M | ¥ -67.20M | ¥ -116.78M |
| Net Income | ¥ -99.98M | ¥ -433.46M | ¥ -145.48M | ¥ -545.73K | ¥ -191.83M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 28.08M | ¥ 246.35M | ¥ 370.11M | ¥ 885.20K | ¥ 390.46M |
| Total Assets | ¥ 1.37B | ¥ 1.51B | ¥ 1.72B | ¥ 201.03M | ¥ 91.37K |
| Total Debt | ¥ 414.40M | ¥ 424.46M | ¥ 498.63M | ¥ 380.59M | ¥ 5.01K |
| Net Debt | ¥ 386.32M | ¥ 178.11M | ¥ 128.52M | ¥ 379.70M | ¥ -390.45M |
| Total Liabilities | ¥ 867.91M | ¥ 927.82M | ¥ 991.30M | ¥ 20.35M | ¥ 70.01K |
| Stockholders' Equity | ¥ 499.75M | ¥ 585.21M | ¥ 728.45M | ¥ 180.68M | ¥ 21.36K |
| Cash Flow | |||||
| Free Cash Flow | ¥ -138.84M | ¥ -339.48M | ¥ -239.52M | ¥ -299.55M | ¥ -351.49M |
| Operating Cash Flow | ¥ -120.98M | ¥ -295.23M | ¥ -182.47M | ¥ -613.23K | ¥ -246.61M |
| Investing Cash Flow | ¥ -17.01M | ¥ -44.25M | ¥ -56.98M | ¥ -200.00M | ¥ -104.24M |
| Financing Cash Flow | ¥ -3.58M | ¥ 205.26M | ¥ 317.45M | ¥ 201.50M | ¥ 739.26M |
LakeShore Biopharma Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.